Literature DB >> 21245181

Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline.

Kristine Yaffe1, Andrea Weston, Neill R Graff-Radford, Suzanne Satterfield, Eleanor M Simonsick, Steven G Younkin, Linda H Younkin, Lewis Kuller, Hilsa N Ayonayon, Jingzhong Ding, Tamara B Harris.   

Abstract

CONTEXT: Lower plasma β-amyloid 42 and 42/40 levels have been associated with incident dementia, but results are conflicting and few have investigated cognitive decline among elders without dementia.
OBJECTIVE: To determine if plasma β-amyloid is associated with cognitive decline and if this association is modified by measures of cognitive reserve. DESIGN, SETTING, AND PARTICIPANTS: We studied 997 black and white community-dwelling older adults from Memphis, Tennessee, and Pittsburgh, Pennsylvania, who were enrolled in the Health ABC Study, a prospective observational study begun in 1997-1998 with 10-year follow-up in 2006-2007. Participant mean age was 74.0 (SD, 3.0) years; 55.2% (n = 550) were female; and 54.0% (n = 538) were black. MAIN OUTCOME MEASURES: Association of near-baseline plasma β-amyloid levels (42 and 42/40 measured in 2010) and repeatedly measured Modified Mini-Mental State Examination (3MS) results.
RESULTS: Low β-amyloid 42/40 level was associated with greater 9-year 3MS cognitive decline (lowest β-amyloid tertile: mean change in 3MS score, -6.59 [95% confidence interval [CI], -5.21 to -7.67] points; middle tertile: -6.16 [95% CI, -4.92 to -7.32] points; and highest tertile: -3.60 [95% CI, -2.27 to -4.73] points; P < .001). Results were similar after multivariate adjustment for age, race, education, diabetes, smoking, and apolipoprotein E [APOE ] e4 status and after excluding the 72 participants with incident dementia. Measures of cognitive reserve modified this association whereby among those with high reserve (at least a high school diploma, higher than sixth-grade literacy, or no APOE e4 allele), β-amyloid 42/40 was less associated with multivariate adjusted 9-year decline. For example, among participants with less than a high school diploma, the 3MS score decline was -8.94 (95% CI, -6.94 to -10.94) for the lowest tertile compared with -4.45 (95% CI, -2.31 to -6.59) for the highest tertile, but for those with at least a high school diploma, 3MS score decline was -4.60 (95% CI,-3.07 to -6.13) for the lowest tertile and -2.88 (95% CI,-1.41 to -4.35) for the highest tertile (P = .004 for interaction). Interactions were also observed for literacy (P = .005) and for APOE e4 allele (P = .02).
CONCLUSION: Lower plasma β-amyloid 42/40 is associated with greater cognitive decline among elderly persons without dementia over 9 years, and this association is stronger among those with low measures of cognitive reserve.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21245181      PMCID: PMC3108075          DOI: 10.1001/jama.2010.1995

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  29 in total

1.  Plasma levels of beta-amyloid (1-42) in Alzheimer's disease and mild cognitive impairment.

Authors:  Marzia Pesaresi; Carlo Lovati; Pierluigi Bertora; Enrico Mailland; Daniela Galimberti; Elio Scarpini; Pierluigi Quadri; Gianluigi Forloni; Claudio Mariani
Journal:  Neurobiol Aging       Date:  2006-04-25       Impact factor: 4.673

2.  Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing.

Authors:  P Lewczuk; J Kornhuber; E Vanmechelen; O Peters; I Heuser; W Maier; F Jessen; K Bürger; H Hampel; L Frölich; F Henn; P Falkai; E Rüther; H Jahn; Ch Luckhaus; R Perneczky; K Schmidtke; J Schröder; H Kessler; J Pantel; H-J Gertz; H Vanderstichele; G de Meyer; F Shapiro; S Wolf; M Bibl; J Wiltfang
Journal:  Exp Neurol       Date:  2009-08-05       Impact factor: 5.330

3.  Neuropathology of older persons without cognitive impairment from two community-based studies.

Authors:  D A Bennett; J A Schneider; Z Arvanitakis; J F Kelly; N T Aggarwal; R C Shah; R S Wilson
Journal:  Neurology       Date:  2006-06-27       Impact factor: 9.910

4.  Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study.

Authors:  Marieke van Oijen; Albert Hofman; Holly D Soares; Peter J Koudstaal; Monique M B Breteler
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

5.  Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Authors:  Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

6.  Endogenous sex hormone levels and risk of cognitive decline in an older biracial cohort.

Authors:  K Yaffe; D Barnes; K Lindquist; J Cauley; E M Simonsick; B Penninx; S Satterfield; T Harris; S R Cummings
Journal:  Neurobiol Aging       Date:  2006-11-09       Impact factor: 4.673

7.  Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.

Authors:  Hiroaki Fukumoto; Marsha Tennis; Joseph J Locascio; Bradley T Hyman; John H Growdon; Michael C Irizarry
Journal:  Arch Neurol       Date:  2003-07

8.  Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study.

Authors:  J-C Lambert; S Schraen-Maschke; F Richard; N Fievet; O Rouaud; C Berr; J-F Dartigues; C Tzourio; A Alpérovitch; L Buée; P Amouyel
Journal:  Neurology       Date:  2009-09-15       Impact factor: 9.910

9.  Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment.

Authors:  Oskar Hansson; Henrik Zetterberg; Eugeen Vanmechelen; Hugo Vanderstichele; Ulf Andreasson; Elisabet Londos; Anders Wallin; Lennart Minthon; Kaj Blennow
Journal:  Neurobiol Aging       Date:  2008-05-19       Impact factor: 4.673

10.  Cognition, reserve, and amyloid deposition in normal aging.

Authors:  Dorene M Rentz; Joseph J Locascio; John A Becker; Erin K Moran; Elisha Eng; Randy L Buckner; Reisa A Sperling; Keith A Johnson
Journal:  Ann Neurol       Date:  2010-03       Impact factor: 10.422

View more
  85 in total

1.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Preferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shift.

Authors:  Mary Jo LaDu; Gregory W Munson; Lisa Jungbauer; Godfrey S Getz; Catherine A Reardon; Leon M Tai; Chunjiang Yu
Journal:  Biochim Biophys Acta       Date:  2011-11-23

3.  The demographic and medical correlates of plasma aβ40 and aβ42.

Authors:  Andrea L Metti; Jane A Cauley; Hilsa N Ayonayon; Tamara B Harris; Caterina Rosano; Jeff D Williamson; Kristine Yaffe
Journal:  Alzheimer Dis Assoc Disord       Date:  2013 Jul-Sep       Impact factor: 2.703

Review 4.  Efficiency, capacity, compensation, maintenance, plasticity: emerging concepts in cognitive reserve.

Authors:  Daniel Barulli; Yaakov Stern
Journal:  Trends Cogn Sci       Date:  2013-09-07       Impact factor: 20.229

Review 5.  Defining Cognitive Reserve and Implications for Cognitive Aging.

Authors:  Corinne Pettigrew; Anja Soldan
Journal:  Curr Neurol Neurosci Rep       Date:  2019-01-09       Impact factor: 5.081

6.  Face-name associative memory performance is related to amyloid burden in normal elderly.

Authors:  Dorene M Rentz; Rebecca E Amariglio; J Alex Becker; Meghan Frey; Lauren E Olson; Katherine Frishe; Jeremy Carmasin; Jacqueline E Maye; Keith A Johnson; Reisa A Sperling
Journal:  Neuropsychologia       Date:  2011-06-12       Impact factor: 3.139

7.  Factors affecting Aβ plasma levels and their utility as biomarkers in ADNI.

Authors:  Jon B Toledo; Hugo Vanderstichele; Michal Figurski; Paul S Aisen; Ronald C Petersen; Michael W Weiner; Clifford R Jack; William Jagust; Charles Decarli; Arthur W Toga; Estefanía Toledo; Sharon X Xie; Virginia M-Y Lee; John Q Trojanowski; Leslie M Shaw
Journal:  Acta Neuropathol       Date:  2011-07-30       Impact factor: 17.088

8.  Long-term cumulative depressive symptom burden and risk of cognitive decline and dementia among very old women.

Authors:  Adina Zeki Al Hazzouri; Eric Vittinghoff; Amy Byers; Ken Covinsky; Dan Blazer; Susan Diem; Kristine E Ensrud; Kristine Yaffe
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2013-10-04       Impact factor: 6.053

9.  β-amyloid dynamics in human plasma.

Authors:  Yafei Huang; Rachel Potter; Wendy Sigurdson; Tom Kasten; Rose Connors; John C Morris; Tammie Benzinger; Mark Mintun; Tim Ashwood; Mats Ferm; Samantha L Budd; Randall J Bateman
Journal:  Arch Neurol       Date:  2012-12

10.  Longitudinal Cognitive Trajectories of Women Veterans from the Women's Health Initiative Memory Study.

Authors:  Claudia B Padula; Julie C Weitlauf; Allyson C Rosen; Gayle Reiber; Barbara B Cochrane; Michelle J Naughton; Wenjun Li; Michelle Rissling; Kristine Yaffe; Julie R Hunt; Marcia L Stefanick; Mary K Goldstein; Mark A Espeland
Journal:  Gerontologist       Date:  2015-11-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.